REPLIGEN CORP
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $738.3M | $634.4M | $632.4M | $801.5M | $670.5M |
| Operating income | $55.2M | -$35.1M | $47.7M | $224.7M | $167.2M |
| Cost of revenue | $352.0M | $359.8M | $353.9M | $345.8M | $279.3M |
| Cash from operations | $117.4M | $175.4M | $113.9M | $172.1M | $119.0M |
| Capital expenditure | $23.5M | $25.7M | $36.2M | $84.8M | $67.1M |
| Free cash flow | $93.9M | $149.7M | $77.7M | $87.2M | $51.9M |
| Share repurchases | $0 | $0 | $14.4M | $0 | $0 |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $2.9B | $2.8B | $2.8B | $2.5B | $2.4B |
| Total liabilities | $843.6M | $856.9M | $866.3M | $620.9M | $608.3M |
Shares outstanding 56.4M · Free float 90.9%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.